Activity-dependent neuroprotective protein (ADNP) differentially interacts with chromatin to regulate genes essential for embryogenesis  by Mandel, Shmuel et al.
Developmental Biology 303 (2007) 814–824
www.elsevier.com/locate/ydbioGenomes & Developmental Control
Activity-dependent neuroprotective protein (ADNP) differentially interacts
with chromatin to regulate genes essential for embryogenesis
Shmuel Mandel a, Gideon Rechavi b, Illana Gozes a,⁎
a Department of Human Molecular Genetics and Biochemistry, Tel Aviv University, Tel Aviv 69978, Israel
b Cancer Research Center, The Chaim Sheba Medical Center, Sackler Medical School, Tel Aviv University, Tel Aviv 69978, Israel
Received for publication 3 September 2006; accepted 21 November 2006
Available online 1 December 2006Abstract
Complete deficiency in activity-dependent neuroprotective protein (ADNP) results in neural tube closure defects and death at days 8.5–9.5 of
gestation in the mouse (E8.5–9.5). To elucidate ADNP associated pathways, Affymetrix 22,690-oligonucleotide-based microarrays were used on
ADNP knockout and control mouse embryos (E9) separated completely from extra embryonic tissue. Marked differences in expression profiles
between ADNP-deficient embryos and ADNP-expressing embryos were discovered. Specifically, a group of dramatically up-regulated gene
transcripts in the ADNP-deficient embryos were clustered into a family encoding for proteins enriched in the visceral endoderm such as
apolipoproteins, cathepsins and methallotionins. In contrast, a down regulated gene cluster associated with ADNP-deficiency in the developing
embryo consisted of organogenesis markers including neurogenesis (Ngfr, neurogenin1, neurod1) and heart development (Myl2). The pluripotent
P19 cells were used for ADNP-chromatin-immunoprecipitation, showing direct interactions with multiple relevant gene promoters including
members of the up-regulated as well as the down-regulated gene clusters. A comparison between non-differentiated and neuro-differentiated P19
cells revealed increased chromatin interaction of ADNP with chromatin from differentiated cells. These results place ADNP at a crucial point of
gene regulation, repressing potential endoderm genes and enhancing genes associated with organogenesis/neurogenesis.
© 2006 Elsevier Inc. All rights reserved.Keywords: ADNP; Gene array; Chromatin immunoprecipitation; P19; Visceral endoderm; Organogenesis/neurogenesis; Knockout embryosIntroduction
Activity-dependent neuroprotective protein (ADNP) is a 9
zinc finger, homeodomain containing protein possessing a
putative transcription factor activity that was discovered in our
laboratory (Bassan et al., 1999; Zamostiano et al., 2001). The
ADNP homeodomain shows high similarity to the homeobox
domain of the HOX protein family (USCA, Genome
database), DNA-binding factors that are known to be involved
in the transcriptional regulation of key developmental pro-
cesses (Hombria and Lovegrove, 2003). ADNP contains a
nuclear localization signal, as well as cellular export and
import signals suggesting nuclear, cytoplasmic and extra-⁎ Corresponding author. The Lily and Avraham Gildor Chair for the
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doi:10.1016/j.ydbio.2006.11.039cellular functions (Furman et al., 2004; Gozes, 2001;
Zamostiano et al., 2001).
ADNP is highly conserved in human, mouse and rat (Bassan
et al., 1999; Sigalov et al., 2000; Zamostiano et al., 2001) and is
overexpressed in malignant cells (Zamostiano et al., 2001).
Expression of ADNP in mouse embryos was first detected at
gestational day E7.5, peaked at E9, and reached its basal
constitutive levels thereafter (Pinhasov et al., 2003; Poggi et al.,
2002). Whole mount in situ hybridization showed high
expression of ADNP in the developing embryonic brain and
nervous system as well as lower expression in the rest of the
embryonic body (Pinhasov et al., 2003).
Previous work has shown that ADNP acts as a vasoactive
intestinal peptide (VIP) responsive gene (Bassan et al., 1999;
Gozes et al., 2000; Pinhasov et al., 2003; Zusev and Gozes,
2004) and that VIP regulates embryonic development (Gressens
et al., 1993; Hill et al., 1999). VIP has been shown to enhance
the release of ADNP from glial cells (Furman et al., 2004) and
in turn recombinant ADNP was shown to produce cellular
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2006). An important neuroprotective active site on ADNP is a
short eight amino acid peptide termed NAP (NAPVSIPQ)
(Gozes et al., 2005) that provides neuroprotection through
interaction with microtubules (Divinski et al., 2006). During
embryonic development, NAP was shown to enhance neural
tube closure that is inhibited by alcohol exposure (Chen et al.,
2005).
To understand the physiological significance of ADNP,
knockout mice were developed which showed marked growth
retardation with E9.0 ADNP knockout (KO) embryos exhibi-
ting an E8.0 phenotype. Furthermore, neural tube closure was
inhibited in the ADNP KO embryos and at embryonic day 9.5
(E9.5), in utero absorption took place (Pinhasov et al., 2003).
During mouse embryogenesis, the period from E8.5 to 10.5
encompasses a series of major developmental events. These
include formation of the neural tube, the central nervous system
primordium, which initiates at the cervical–hindbrain boundary
at E8.5 and is completed at E10.5 following closure of the
posterior neuropore. Other events during this interval include
axial rotation, formation of differentiated somites, extensive
remodeling of the heart with onset of regular contractions and
placental chorioallantoic development (Greene et al., 2002).
Previous studies have shown that during this stage of ontogeny,
ADNP has a regulatory effect on genes such as PAX6 and
OCT4 that are crucial for the development of the nervous
system and for the maintenance of stem cells, respectively
(Pinhasov et al., 2003). However, the mechanism by which
ADNP exerts its vital developmental effects remains unknown.
In this study, we set out to elucidate the pathways involving
ADNP activities during embryonic development and neurogen-
esis utilizing Affymetrix 22,690-oligonucleotide-based micro-
arrays. Two model systems were used: the ADNP knockout
mice and the model P19 cell line that can differentiate into
neuronal-like cells. The results indicate dual participation for
ADNP in the repression of a large set of genes that are
associated with extra-embryonic tissues and in the enhancement
of the expression of multiple genes associated with organogen-
esis, which enable proper embryonic development.
Materials and methods
Embryo dissections
All procedures involving animals have been approved by the Animal Care
and Use Committee Tel Aviv University. ADNP heterozygous mice were
checked for plug every 3 h. Plug day was assigned as day 0 (E0). A definitive
determination of the developmental stage of each embryo at the time of
harvesting was based on Theiler stages as before (Pinhasov et al., 2003). E9
whole embryos were separated from the extra embryonic tissue (yolk sac and
amnion), immersed in ice-cold magnesium- and calcium-free phosphate-
buffered saline, snap-frozen in liquid nitrogen, and stored at −80 °C until
analysis. The extra embryonic tissue was stored separately and used for
genotyping.
Primers
Primer pairs were designed using the primer 3 web interface (Rozen and
Skaletsky, 2000) and synthesized by Sigma-Genosys (The Woodlands, TX).
Primer sequences are shown in Table 1.Genotyping and RNA extraction
To determine the embryonic genotype, DNAwas extracted from embryonic
yolk sacs and subjected to polymerase chain reaction (PCR) as described (Zusev
and Gozes, 2004) using the neomycin and ADNP primers (Table 1). Two
embryos from the same genotype and gestational time were pooled and RNA
was isolated using Qiagene RNeasy mini kit (Qiagene, Hilden, Germany).
Because of the small amounts of RNA extracted from one embryo at age E9
(∼1.5 μg) a two embryo pool comprised of littermates possessing the same
genotype was used. For comparative experiments all embryos were at
approximately the same age. The same RNA extraction procedure was used
on tissue culture cells.
Gene array
All experiments were performed using Affymetrix MOE430A oligonucle-
otide arrays, as described at http://www.affymetrix.com/products/arrays/
specific/mouse430a_2.affx. Total RNA from each sample was used to prepare
biotinylated target RNA, with minor modifications from the manufacturer's
recommendations (http://www.affymetrix.com/support/technical/manual/
expression_manual.affx).
Briefly, 3–5 μg of mRNAwas used to generate first-strand cDNA by using
a T7-linked oligo(dT) primer. After second-strand synthesis, in vitro transcrip-
tion was performed with biotinylated UTP and CTP (Enzo Diagnostics),
resulting in approximately 100-fold amplification of RNA. A complete descrip-
tion of procedures is available at: http://bioinf.picr.man.ac.uk/mbcf/downloads/
GeneChip_Target_Prep_Protocol_CRUK_v_2.pdf.
The target cDNA generated from each sample was processed according
to manufacturer's recommendation using an Affymetrix GeneChip Instrument
System (http://www.affymetrix.com/support/technical/manual/expression_
manual.affx). Briefly, spike controls were added to 10 μg fragmented
cDNA before overnight hybridization. Arrays were then washed and stained
with streptavidin–phycoerythrin, before being scanned on an Affymetrix
Gene Chip scanner. A complete description of these procedures is available
at http://bioinf.picr.man.ac.uk/mbcf/downloads/GeneChip_Hyb_Wash_Scan_
Protocol_v_2_web.pdf Additionally, quality and amount of starting RNA was
confirmed using an agarose gel. After scanning, array images were assessed by
eye to confirm scanner alignment and the absence of significant bubbles or
scratches on the chip surface. 3′/5′ ratios for GAPDH and beta-actin were
confirmed to be within acceptable limits (0.8–0.88), and BioB spike controls
were found to be present on all the arrays, with BioC, BioD and CreX also
present in increasing intensity. When scaled to a target intensity of 100 (using
Affymetrix MAS 5.0 array analysis software), scaling factors for all arrays were
within acceptable limits (0.607–0.982), as were background, Q values and mean
intensities. Details of quality control measures can be found (after publication of
this article) at http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?=GSE4068.
Array analysis
In order to identify genes that were expressed differentially between the
three genotypes, we used the Expander analysis software. Before applying the
test, intensity levels below 20 were excluded (to reduce identification of changes
at the noise level), and probes flagged as absent filtered out from the analyzed
data. Functional and promoter analysis also used the Expander software (Sharan
et al., 2003) and PRIMA program (Elkon et al., 2003).
Quantitative real time RT-PCR
Confirmatory quantitative gene-specific RT-PCR was performed using
specific primers (Table 1). Total RNAwas independently extracted fromWTand
ADNP null embryos using Qiagene RNeasy mini kit (Qiagene, Hilden,
Germany), treated by DNaseI (Ambion, Ausin, TX) and 1 μg RNA/sample was
reverse-transcribed by SuperScript III reverse transcriptase (200 U, Invitrogene,
Carlsbad, CA) using oligo(dT)20 primers (1 h at 50 °C, 5 min at 85 °C). Real-
time RT-PCR was performed using FastStart DNA Master SYBR Green 1 dye-
base detection kit (Roche Diagnostics Manncheim, Germany). We used the
Light Cycler instrument with its internal relative quantification software (Roche
Table 1
Primer Sequence Annealing temperature Size of product
ADNP (genomic) 5′ GTCCGTTACAGATTGTAC 3′ 51 °C 382
5′ CTGCAGCAAAACAACTAT3′
ADNP (for Real time PCR) 5′ CGAAAAATCAGGACTATCGG 3′ 60 °C 240
5′ TGAAAGTGCTGAGGCTGCTA3′
Neomycin 5′ ATGAATCCAGAAAAGCGGC 3′ 57 °C 290
5′ ATCTCCTGTCATCTCACCT3′
Neurogenine1 5′-GACACTGAGTCCTGGGGTTC-3′ 60 °C 191
5′-GGCCTAGTGGTATGGGATGA-3′
NeuroD1 5′-TGACCTTTCCCATGCTGAAT-3′ 60 °C 213
5′-AAGTGCTAAGGCAACGCAAT-3′
Galanin (Gal) 5′-TCATTTAGCGACAAGCATGG-3′ 60 °C 232
5′-CAGTGGACATGGTCTCAGGA-3′
Myosin light chain 2 (Myl2) 5′-GACCCAGATCCAGGAGTTCA-3′ 60 °C 162
5′-ATTGGACCTGGAGCCTCTTT-3′
Nerve growth factor receptor (Ngfr) 5′-TTTTGCTTGCTGTTGGAATG-3′ 60 °C 150
5′-AAATACCACCGAGCACAAGG-3′
Apolipoprotein E (ApoE) 5′-GGTTCGAGCCAATAGTGGAA-3′ 60 °C 209
5′-TATTAAGCAAGGGCCACCAG-3′
ApolipoproteinA1 (apoA1) 5′-GTGGCTCTGGTCTTCCTGAC-3′ 60 °C 218
5′-ACGGTTGAACCCAGAGTGTC-3′
Cathepsin L (CtsL) 5′-GTGGACTGTTCTCACGCTCA-3′ 60 °C 410
5′-TATCCACGAACCCTGTGTCA-3′
Cathepsin Z (CtsZ) 5′-CACCAGGACCAGGCTGTTAT-3′ 60 °C 150
5′-CTTGTAGGTGCTGGTCACGA-3′
Metallothionei1 (Mt1) 5′-ACCTCCTGCAAGAAGAGCTG-3′ 60 °C 159
5′-GCTGGGTTGGTCCGATACTA-3′
SerpinF2 5′-CAAGCTTAGACTGGCCTTGG-3′ 60 °C 160
5′-GAGGAAGACTCCTGGCAGTG-3′
L19 5′-CTGAAGGTCAAAGGGAATGTG-3′ 60 °C 580
5′-GGACAGAGTCTTGATGATCTC-3′
Actin 5′-TGTTACCAACTGGGACGACA-3′ 60 °C 165
5′-GGGGTGTTGAAGGTCTCAAA-3′
Metallothionein-I promoter 5′-AGCCCCCTCAGGAGTAGAGA-3′ 60 °C 434
5′-CTCCAGCCCACGCATAGT-3′
apoE promoter 5′-GGGAGAGAACAACCCGCC-3′ 60 °C 105
5′-GGATCCCAGACCGGTCCA-3′
CtsC promoter 5′-TGTCAACCCTGTATTGCACAG-3′ 60 °C 400
5′-TTCAACTGGAACACCACTCG-3′
Ctsz promoter 5′-ATGACCCACACCTTCTTCCA-3′ 60 °C 383
5′-GCCCAAGTTGGACACACC-3′
Myl2 promoter 5′-TTCCTCTTCCTCTCCCCTTC-3′ 60 °C 404
5′-CCCCTGCTGTGGAACAATAA-3′
Neurogn1 promoter 5′-CGACATCACTCAGGAGACCA-3′ 60 °C 160
5′-TTCGAAGCGCACTTACTGTC-3′
L19 promoter 5′-AGAGGACCACGTGACCAAAC-3′ 60 °C 232
5′-CGAAAGGAAAGAGCTTGTGG-3′
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assess the specificity of the amplified genes. All reactions were performed with a
magnesium chloride concentration of 2.5 mM, primer concentrations of 0.5 μM,
and 2.5 μl of the reverse transcription product in a 10 μl reaction mixture.
Annealing temperature was 60 °C for all genes checked. Relative quantification
was performed by normalized ratio of ADNP-to-actin expression. Size was
verified by melting curve analysis and agarose gel electrophoresis.
P19 cells
Embryonic carcinoma cells were obtained from the American Type Culture
Collection (ATCC, Bethesda, MD); an initial control batch was a kind gift of Dr.
Roi Atlas and Professor Irith Ginzburg. To induce neural differentiation, 1×106
aggregated P19 cells were cultivated in 90 mm bacteriological grade dishes in
10 ml of alpha-MEM containing 10% fetal calf serum, 100 units/ml penicillin
and 100 mg/ml streptomycin (Biological Industries, Beit Haemek, Israel) in an
incubator with 5% CO2/37 °C and 1 μM all–trans retinoic acid (RA; Sigma, St.Louis, MO) for 4 days as described previously (Akiyama et al., 2003). Cell
aggregates were suspended with trypsin-C (Biological Industries Beit Haemek,
Israel) and transferred to tissue culture dishes. The cells were cultivated in RA
free alpha-MEM containing 10% fetal calf serum for additional 4 days to induce
neuronal and astroglial phenotype. All RNA extractions and real time PCR
procedures were preformed on the P19 cells before, during and after retinoic
acid-induced-differentiation.
Antibodies
Rabbit polyclonal anti C-terminal-ADNP (BL1034) were obtained from
Bethyl Laboratories (Montgomery, TX). Rabbit polyclonal antibodies created in
our laboratory against the hADNP epitops 1087–1101 and 185–199—anti C-
terminal-ADNP (anti 79) and anti N-terminal-ADNP (anti 70) respectively (Miri
Holtser-Cochav, Karin Vered and Illana Gozes, unpublished results). A purified
IgG fraction was prepared by using AffinityPak prepacked columns of
immunopure plus immobilized protein A (Pierce, Rockford, IL). Other
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BD Biosciences, Franklin Lakes, NJ), rabbit polyclonal anti HP1α (Sigma, St.
Louis, MO) and non-specific IgG from rabbit serum-(#15006, Sigma, St. Louis,
MO), beta 3 tubulin as before (Divinski et al., 2006) and non-specific IgG from
rabbit serum-(#15006, Sigma, St. Louis, MO). Secondary antibodies were goat
anti-mouse-HRP (Jackson ImmunoResearch, West Grove, PA), goat anti-rabbit-
HRP (Sigma St. Louis, MO) and HRP protein-A (Amersham Biosciences,
Buckinghamshire, UK).
Chromatin immunoprecipitation assay
The chromatin immunoprecipitation (ChIP) assay was carried out following
published protocols (Wells and Farnham, 2002) with slight modifications. In
brief, P19 cells were cross-linked with formaldehyde (1% final concentration)
for 10 min. All further manipulations were carried out at 4 °C. Cells were rinsed
with PBS and lysed in SDS lysis buffer (1% SDS, EDTA 10 mM, Tris–HCl pH
8.1, 1× protease inhibitor cocktail (Sigma St. Louis, MO), for 30 min. The
lysates were then re-suspended and chromatin was sonicated to an average DNA
length of 500–1000 bp and then centrifuged at 16,000×g for 10 min. The
supernatants were collected and diluted 10-fold in 0.01% SDS, 1% Triton X-
100, 1.2 mM EDTA , 16.7 mM Tris HCl, pH 8.1, 167 mM NaCl with protease
inhibitors (Sigma, St. Louis, MO ) and subjected to immunoprecipitation with
rabbit anti ADNP (Bethyl, anti 79 or anti 70 as described above) or non-specific
rabbit IgG for 16 h. Immunocomplexes were collected by adsorption onto 25 μl
protein A/G sepharose beads (Santa Cruz Biotechnologies, Santa Cruz, CA) forFig. 1. ADNP-deficiency morphologic and genetic analysis. (A) Morphology of E9–
photographs show freshly dissected littermates, ADNP−/− embryos are markedly sm
place under normal conditions on E8.0–E9.5; (Pinhasov et al., 2003)]. (B) Total RNA
(total embryos used=14, 2 embryos/array, totaling seven arrays). Two distinct clust16 h. The beads were washed sequentially with low salt wash buffer (0.1% SDS,
1% Triton X-100, 2 mM EDTA, 20 mM Tris–HCl, pH 8, and 150 mM NaCl),
high salt wash buffer (0.1% SDS, 1% Triton X-100, 2 mM EDTA, 20 mM Tris–
HCl, pH 8, and 500 mMNaCl), lithium chloride wash buffer (500 mM LiCl, 1%
Nonidet P-40, 1% sodium deoxycholate, and 100 mM Tris–HCl, pH 8).
Precipitates were washed with TE buffer (10 mM Tris–HCl, pH 8, 1 mM
EDTA), and antibody-bound chromatin fragments were eluted from the beads
with 1% SDS in 10 mMNaHCO3. Cross-links were reverted by heating at 65 °C
overnight. DNAwas recovered using phenol chloroform DNA precipitation and
analyzed for specific gene promoter sequences by PCR (as described above).
ChIP DNA was amplified using 27–30 cycles. Primers used for analysis are
listed in Table 1. The amplification product generated by each primer set is
located within 300 bases of the putative initiation site of RNA transcription, as
determined by sequence information available on the NCBI and UCSC genomic
databases.
ADNP, HP1α coimmunoprecipitation
Nuclear proteins were extracted from P19 cells using Pierce NE-PER
nuclear extraction buffer (Pierce, Rockford, IL) according to the manufac-
turer's protocol and supplemented with protease inhibitors cocktail (Sigma St.
Louis, MO). Nuclear proteins were used for ADNP/ HP1α immunoprecipi-
tation, using anti ADNP (Bethyl, Montgomery, TX), HP1α (Upstate, Lake
Placid, NY) or non-specific rabbit IgG antibodies. 2 μg of each of the
antibodies was added to P19 nuclear extracts and the sample was rotated9.5 wild type (WT=ADNP+/+) and knockout (KO=ADNP−/−) embryos. The
aller than the ADNP+/+ embryos, and do not go through axial rotation [taking
from two E9 genotype-identical littermates was used on each Affymetrix array
ers of differential gene expression are shown.
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25 mM HEPES pH 7.4, and 75 mM NaCl) with a protease inhibitors cocktail
(Sigma St. Louis, MO). Pre-cleared slurry (30 min rotation with beads at 4 °C
before antibody addition) was supplemented with protein A/G Plus agarose
beads (30 μl; Santa Cruz Biotechnology, Santa Cruz, CA) and the mixture wasFig. 2. Patterns of expression and functional/promoter analysis of ADNP KO mice.
ADNP manipulation were further analyzed. The Expander clustering program (http
graph the homogeneity of the up-regulated and down-regulated gene clusters. Diffe
arrays, Fig. 1) and wild type (WT–two arrays, Fig. 1) embryos are shown. (B) Analy
performed (http://www.cs.tau.ac.il/∼rshamir/expander/ver3Help.html#Group_Anal).
marked in bold showed dramatic changes and were used as group representatives for
transcription factors consensus binding sites that were enriched in the two clusters (u
E9 embryos was subjected to QR-PCR and the products were quantified during the
gene. The values represent the ratios of ADNP KO/WT gene expression (n=3, Studincubated for 1 h at 4 °C. The protein sample was then subjected to cen-
trifugation at 2000×g for 1 min to pellet the beads and the supernatant was
removed. The beads were then washed four times with wash buffer (similar to
the binding buffer, above), followed by a wash with PBS. Sample-buffer was
added to the beads and the samples were boiled for 10 min. Proteins were(A) Only genes that showed >2-fold change in expression as a consequence of
://www.cs.tau.ac.il/∼rshamir/expander/ver3Help.html#Clustering) was used to
rences between the knockout (KO–two arrays, Fig. 1), heterozygous (H, three
sis that combines genes with common destiny to generate functional groups was
The significance value and the genes constituting the groups are shown. Genes
further analysis (below). (C) The Expander software promoter analysis revealed
p or down regulated genes). (D) Complementary DNA from WT and KO ADNP
linear phase of amplification. Cytoplasmic β-actin (actin) was used as a control
ent's t-test *p<0.05, **p<0.005).
Fig. 2 (continued )
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(SDS–PAGE), as described below.
SDS–PAGE and Western analysis
SDS–PAGE for ADNP and HP1α was performed essentially as described
(Zamostiano et al., 2001). In brief: proteins (20 μg lane) were separated by
electrophoresis on a 10% (w/v) polyacrylamide gel (BioRad, Hercules, CA)
containing 0.1% SDS. Molecular weights were determined using Wide Range
(6–250 kDa) Multicolored Protein Markers (See Blue, Invitrogen, Carlsbad,
CA). The proteins were transferred to PVDF membranes (Invitrogen, Carlsbad,
CA) and non-specific antigen sites were blocked using a solution containing 5%
non-fat dried milk (w/v) in 10 mM Tris pH 8, 150 mM NaCl and 0.05% Tween
20. Antigen detection was performed using anti Bethyl-ADNP (1:2,000) or anti
HP1α (1:1,000).
Antibody–antigen complexes were detected using horseradish peroxidase
conjugated secondary protein A (1:5,000, Amersham Biosciences, Buckin-
ghamshire, UK) and visualized by ECL Plus Western blotting detection system
(Amersham Biosciences Buckinghamshire, UK).
Results
Gene expression profiling of the ADNP knockout embryo
To identify downstream target genes of ADNP, we examined
global gene expression profiles of whole E9 knockout embryos
(KO–ADNP−/−), their wild-type (WT–ADNP+/+) and their
heterozygous (H–ADNP−/+) littermates, using the Affymetrix
Murine Genome 430A oligonucleotide microarrays. E9 embry-
os were chosen because it is the period by which embryos
lacking ADNP exhibit distinct morphological and developmen-
tal changes just prior to degeneration and in utero absorption
(Fig. 1A). ADNP E9 knockout mouse embryos do not complete
axial rotation and neural tube closure. Morphologically,embryonic development of the ADNP knockout mice halts at
E8–E8.5. No visible abnormalities were detected in the extra
embryonic tissues (visceral yolk sac and amnion). Heterozy-
gous embryos undergo normal embryogenesis, albeit with slight
developmental delays (Pinhasov et al., 2003).
Total RNA was extracted from four ADNP knockout
embryos, four normal embryos and six heterozygous embryos
completely devoid of extra embryonic tissue. A pool of two
genotype identical littermates was used on seven different
arrays (pooling of two embryos was necessary to obtain
sufficient RNA for the microarray analysis). Gene expression
results were analyzed using the novel Expander software
(Sharan et al., 2003). From the 22,690 probes on the array,
only 13,814 showed a significant signal (i.e. were present on
the array and showed expression intensity >20 arbitrary units)
indicating that these genes were expressed at the E9 stage of
embryonic development. The data were normalized using
quintiles normalization (Bolstad et al., 2003) in order to
remove systematic variation arising from reasons other than
biological differences between RNA samples. Data were then
analyzed by comparing gene expression levels in the knockout
embryos with that of normal and heterozygous embryos (Fig.
1B). Fold change of gene expression levels was used as the
filtering criteria for selecting genes of interest. Two sets of
gene lists were generated from 469 genes that showed >2 fold
change between the ADNP expressing (normal and heterozy-
gous) and the KO embryos, 248, up-regulated genes and 221,
down-regulated genes. It is interesting to note that among the
469 genes exhibiting >2 fold change in expression in the
ADNP KO embryos, 211 genes showed a distinct differential
expression of >3 fold change between the KO embryos and the
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(Fig. 2A).
Functional analysis
Each of the up-regulated and down-regulated gene clusters
was analyzed using the Gene Ontology database (Ashburner et
al., 2000) to determine significant functional groups within the
different clusters (Sharan et al., 2003). Six significant functional
groups (P-value<10−4) were generated, three from each cluster
(Fig. 2B). The cluster of genes down-regulated in the knockout
embryos consisted of the following functional groups: regula-
tion of transcription—genes associated with any process that
modulates the frequency, rate or extent of the synthesis of RNA.
Organogenesis—genes related to the determination of morpho-
genesis of a tissue or tissues that work together to perform a
specific function. Neurogenesis—genes related to the origin
and formation of the nervous tissue. All these key processes
were shown to be impaired or delayed in knockout embryos that
were devoid of ADNP expression.
The functional groups deduced from the cluster of up-
regulated genes in the ADNP knockout embryos showed greater
fold changes as compared to the down-regulated genes. Some of
these up-regulated transcripts showed ∼30 fold higher
expression in the KO compared to WT embryos. These up-
regulated genes formulate the following functional groups: lipid
transport—protein associated with the directed movement of
lipids into, out of, within or between cells. Lytic vacuole—
vacuoles maintained at an acidic pH which contains degradative
enzymes, including a wide variety of acid hydrolases.
Coagulation—any process that modulates the frequency, rate
or extent of blood coagulation, including proteases and anti-
proteases that may be associated with embryogenesis. The three
up-regulated sub groups are all included in the functional
extracellular space group, consisting of proteins that participate
in processes outside the cells and included to a large extent in
the visceral endoderm that forms parts of the extra embryonic
tissue. Other genes of significance for the visceral endoderm,
that are not included in the functional groups cited above, were
also up-regulated in the ADNP KO embryos, including, HNF4
DAB2 (Cammas et al., 2002) BMP2 (Maye et al., 2000) and
RBP4 (Johansson et al., 1997). The increase in visceral
endoderm gene expression in ADNP KO embryos is specific
to certain genes and does not include all extra-embryonic tissue
genes, thus excluding the possibility of extra embryonic tissue
contamination. For example, no significant changes in ADNP
KO embryos in comparison to WTembryos were detected in the
expression of extra embryonic tissue associated genes such as
enolase alfa (ENO1), ribosomal protein L13a (RPL13A)
HSP70, cellular nucleic acid binding protein 1 (CNBP) (Palis
and Kingsley, 1995) and OTX2 (Maye et al., 2000).
Promoter analysis
Using genomic binding sequences of known transcription
factors, it is possible to deduce transcriptional networks and
regulatory elements out of gene expression data (Elkon et al.,2003). By calculating the relative occurrence of putative
binding sites on promoters of genes, it is possible to deduce
specific transcription factors that are significantly enriched in
the clusters generated above. The promoters of the genes found
to be up-regulated by ADNP-deficiency were also found to be
enriched in regulatory elements that interact with the following
transcription factors: hepatocyte nuclear factor 1 and 4 (HNF1,
HNF4) and peroxisome proliferative activated receptor,
gamma (PPARG). In contrast, down-regulated genes were
enriched in binding sites to E2F and ZF5 transcription factors
(Fig. 2C). Interestingly, as indicated above, HNF4 gene
transcripts were found to be up-regulated in the ADNP KO
mice.
Microarray data validation
In order to validate the microarray results, quantitative real
time polymerase chain reaction (QR-PCR) was performed as
described before (Sigalov et al., 2000; Zaltzman et al., 2004).
For this purpose, six embryos (E9) were used for RNA
extraction, including three wild type (WT, ADNP+/+) and three
ADNP knockout embryos (KO, ADNP−/−). Galanin (gal),
neurogenin1 (neurog1) and neuroD1 (neuroD1), genes associ-
ated with neurogenesis, organogenesis and transcription control
(Fig. 2) that were down-regulated (>2.5-fold) on the array were
analyzed by QR-PCR. Results showed that the corresponding
transcripts were markedly decreased in the KO mice as
compared to the WT. Of the up-regulated genes, apolipopro-
teinE (apoE) and apolipoproteinA1 (apoA1) were essentially
absent in the WTembryos and highly expressed in the KO mice,
while the cathepsin family of enzymes showed a marked
increase in the KO as compared to the WT embryos (Fig. 2D).
The QR-PCR results are in agreement with the results obtained
by microarray analyses. The genes analyzed represent the three
major functional groups that are up-regulated as a consequence
of ADNP knockout. Expression was normalized relative to
actin, a cytoskeletal protein that did not show a significant
change in expression as a result of ADNP knockout.
Detecting genes downstream in the ADNP cascade
Genes that showed markedly augmented or reduced
expression (>2.5-fold) in the knockout embryos, most likely
in response to ADNP deficiency, were considered as potential
target genes (PTGs) in the ADNP down stream cascade.
To verify the association of these genes with ADNP during
neuronal differentiation, we used the chromatin immunopre-
cipitation assay (ChIP). This method evaluated the putative
direct association between ADNP and a specific PTG. P19, the
pluripotent embryonic carcinoma cell line, was selected as a
model for this assay. This model cell line was chosen because 1]
it has the potential to differentiate into neuronal-like cells,
mimicking, in part, the process of neurogenesis; 2] ADNP was
originally cloned from an expression library derived from P19
cells (Bassan et al., 1999). Six PTG candidates including the up-
regulated apolipoprotein E, cathepsins C, Z and metalotionine 1
and the down-regulated neurogenin 1, and myosin light chain 2
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promoters and ADNP in cultured P19 non-differentiated and
differentiated cells (treated with retinoic acid) chromatin was
extracted and precipitated with antibodies against ADNP.
Primers were constructed to the promoter proximal region of
the PTG candidates and the DNA derived from the ChIP of the
differentiated and non-differentiated P19 cells was assayed for
the presence of PTG candidate promoters. Non-immune rabbit
serum was used as negative control for the specificity of the
antibodies. In the ChIP assay, a PTG is considered positive if the
signal from the specific antibody is higher than that of the non-
immune control. The efficiency of the PCR primers and the
specificity for the correct DNA sequence is demonstrated by the
successful amplification of input non-immunoprecipitated DNA
(Fig. 3A, Input DNA). The ChIP analysis demonstrated that
immunoreactive-ADNP interacted with chromatin that includes
all the six PTG promoters tested in differentiated but not in non-
differentiated P19 cells (Fig. 3A). Neuronal-like differentiation
was induced by retinoic acid and measured by the expression ofFig. 3. Chromatin immunoprecipitation of ADNP target gene promoters from differe
with anti ADNP (Bethyl) was subjected to PCR amplification, agarose gel electropho
ADNP antibody; cont= immunoprecipitation with non-immune antibody; input = ch
cells (7 days after retinoic acid induction) were used. Each gene lane represents DNA
are shown, lanes 1 and 2). Similar results were obtained with another ADNP an
differentiation: Neurogenin1, Neurod1 transcript detection was performed by PC
differentiation (experiments were performed in duplicates as shown in the electrophe
differentiation of the P19 cells to neuronal/glial-like cells, 4 days after the addition of
P19 differentiated cytoplasm (7 days after the addition of retinoic acid) indicate
differentiated.neuronal-specific genes including neurogenin1, Neurod1 and
Tubulinβ3 (Fig. 3B).
ADNP interacts with heterochromatin 1α (HP1α)
The ChIP indicated that ADNP-like immunoreactivity
interacts with the chromatin in neuro-differentiated P19 cells.
It therefore raised the possibility that ADNP interacts with
chromatin binding proteins. Bioinformatics search identified a
conserved potential heterochromatin protein1α (HP1α) binding
motif PxVxL (Thiru et al., 2004) on human, rat and mouse
ADNP (Fig. 4A). HP1α is associated with epigenetic regulation
of gene expression through this conserved HP1α binding motif.
HP1α is associated with the regulation of transcription trough
chromatin interaction with a series of nuclear proteins (Lechner
et al., 2005). HP1α participates in chromatin condensation and
has a well-established function in heterochromatin-mediated
silencing (Eissenberg and Elgin, 2000) that may lead to cellular
differentiation (Cammas et al., 2002) and change its degree ofntiated and non-differentiated P19 cells. (A) P19 chromatin immunoprecipitated
resis and ethidium bromide staining. Gel lanes 1, 2=immunoprecipitation with
romatin prior to immunoprecipitation. Non-differentiated and differentiated P19
precipitated in one independent experiment (two out of three such experiments
tibody (anti 79) described in Materials and methods). (B) Markers for P19
R followed by agarose gel electrophoresis indicating progress in neuro/glial
rogram). The expression of the above mentioned proteins was analyzed during
retinoic acid. Western analysis of the tubulinβ3 protein (Divinski et al., 2006) in
d that the cell acquired the neuronal cell fate. D—differentiated, ND—non-
Fig. 4. ADNP interacts with HP1α. (A) Bioinformatic analysis identified a canonical HP1α binding site on ADNP (Thiru et al., 2004). (B) Immunoprecipitation with
either ADNP antibodies (mouse monoclonal anti ADNP antibodies, BD Biosciences) or HP1α antibodies (rabbit polyclonal, Sigma) resulted in co-
immunoprecipitation of both proteins. Precipitation was preformed on both differentiated (D) P19 and none differentiated (ND) P19 cells. Rabbit non-specific
serum was used as specificity Control. The immunoprecipitated proteins were subjected to polyacrylamide gel electrophoresis as described in Materials and methods.
Scheme 1. ADNP regulatory pathways.
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immunoprecipitation on differentiated and non differentiated
P19 nuclear protein extracts it was shown that a low amount of
HP1 α-like immunoreactivity was recovered after immunopre-
cipitation with ADNP antibodies and similarly ADNP-like
immunoreactivity was recovered after immunoprecipitation
with HP1 α antibodies (Fig. 4B). These results suggest that
HP1 αmay be a binding partner of ADNP. Furthermore, the co-
immunoprecipitation assays suggest that ADNP and HP1α co-
interact both in differentiated and in non differentiated cells
(Fig. 4B).
Discussion
The current study suggests that ADNP is associated with the
regulation of multiple gene families during embryonic devel-
opment. These gene families include: key transcription factors,
essential genes associated with neurogenesis/organogenesis,
lytic vacuoles and lipid transport. Representative up-regulated
genes as a result of ADNP KO included apolipoprotein E,
apolipoprotein A1 (∼30-fold), metalotionine1 (∼8-fold) and
cathepsins C, Z (∼2–4-fold). Representative down-regulated
genes included myosin light chain 2 (∼12-fold) and neuro-
genin1 (∼5-fold). ADNP-KO lethality could thus be explained
by the massive changes in essential gene expression that impact
the development of vital organs including the heart (Huang et
al., 2003), the liver (Terasawa et al., 1999) and the nervous
system (Pinhasov et al., 2003).
Promoter analysis identified HNF4 regulatory elements
shared by the up-regulated gene transcripts. The HNF4 gene
itself that is known to be associated with hepatic development
(hepatic nuclear factor 4) was up-regulated by more then 3 fold
as a consequence of ADNP-deficiency.
In view of the above cited findings that imply multiple gene
regulation by ADNP during organogenesis, we opted to first
study neuronal differentiation in a well defined cell line.Chromatin immunoprecipitation with ADNP antibodies in
retinoic acid neuro/glial differentiated P19 cells identified
interaction of ADNP with the chromatin containing the above-
mentioned specific gene promoters. In contrast, ADNP did not
interact with these promoters at the non-differentiated plurip-
otent stage. These results suggest interaction of ADNP with
chromatin proteins that change with cellular differentiation. One
candidate binding partner is HP1 α. Taken together, the data
obtained strengthen the hypothesis that ADNP is involved
either directly or indirectly in the regulation of multiple gene
products through chromatin interactions at a crucial point of
embryogenesis/neurogenesis.
Gene transcripts up-regulated in the ADNP KO embryos
shown to be directly associated with ADNP through the ChIP
assay included apolipoproteinE, cathepsinC, cathepsinZ and
methallotionein1. These gene products are part of the functional
groups of lipid transport and metabolism as well as lytic vacuole
823S. Mandel et al. / Developmental Biology 303 (2007) 814–824activity that constitutes visceral yolk sac/liver-like functions at
E7–10 (Palis and Kingsley, 1995; Terasawa et al., 1999).
Lipoprotein synthesis and secretion is essential during embry-
onic development, especially at mid gestation (Terasawa et al.,
1999). It has also been established that prior to development of
the chorioallentoic placenta, the supply of amino acids to the
developing embryo is mediated by the visceral yolk sac
(Freeman et al., 1981) and a majority of the amino acids
incorporated into embryonic proteins are derived from proteins
hydrolyzed in this tissue by cathepsins among other lysosomal
proteases (Beckman et al., 1996). The current results indicate
that ADNP plays a role in the regulation of genes associated
with extra embryonic tissue at the stage of neural tube closure in
the developing embryo. We hypothesize that the absence of
ADNP that leads to increase in visceral endoderm-associated
gene expression contributes to the arrest of embryogenesis/
neurogenesis. Interestingly, visceral endoderm can induce
anterior epiblast tissue, destined to make neural ectoderm, to
differentiate into hematopoietic cells (Belaoussoff et al., 1998).
Here, we found that in the absence of ADNP there is an increase
in proteins destined to be expressed in the plasma (the
extracellular space functional group) (Thomas et al., 1990)
implying a mechanism that involves ADNP. In addition,
apolipoproteinE and the cathepsin family of proteases have
been associated with Alzheimer's disease, with apolipoprotein
E4 being a risk factor (Nicodemus et al., 2004) and impaired
metabolism of cathepsins may contribute to disease progression
(Hook et al., 2005).
The ChIP assay suggests that ADNP is a chromatin binding
protein and bioinformatic analysis as well as the co-immuno-
precipitation assays indicate that a potential protein binding
partner of ADNP is HP1α. HP1α has been associated with
cellular differentiation as follows. (1) It has been associated
with heterochromatin recruitment in f2 mouse carcinoma cells
induced to differentiate into endoderm-like cells by retinoic acid
(Cammas et al., 2004). (2) Is the only member of the HP1 family
interacting with the centromeric heterochromatin during cell
division (Hayakawa et al., 2003). (3) It has been associated with
the silencing of E2F-target genes (Williams et al., 2003). Here
we show that: (1) The expression of E2F target genes is
decreased in ADNP-deficient mice, and (2) HP1α and ADNP
co-immunoprecipitate. It is may be hypothesized that ADNP is
associated in part with HP1α chromatin interactions which may
influence cell fate and epigenic regulation.
In conclusion, our current data suggest a role for ADNP in a
cascade of events that controls embryonal development, with its
deletion having effects on neurogenesis/cardiogenesis through
suppression of visceral endoderm associated genes (and
hepatogenesis) in the developing embryonic body (Scheme 1).
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